Michael O’Dwyer

Professor of Heamatology
University of Galway

Michael O’Dwyer is Professor of Haematology at the University of Galway. A Clinician Scientist with a keen interest in immunotherapy, he founded ONK Therapeutics in 2015 to develop off the shelf cellular immunotherapy based on natural killer (NK) cells and served as CSO until the end of 2022. ONK Therapeutics is currently undertaking IND enabling work to bring its first product, a CD38 CAR-NK cell to the clinic for the treatment of Multiple Myeloma.